Primary HIV infection with acute transverse myelitis

Internal Medicine

Volumn 50, Issue 15, 2011, Pages 1615-1617

  Hamada, Yohei ^a   Watanabe, Koji ^a   Aoki, Takahiro ^a   Arai, Noritoshi ^a   Honda, Miwako ^a   Kikuchi, Yoshimi ^a   Oka, Shinichi ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Acute transverse myelitis; cART; Primary HIV infection

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; METHYLPREDNISOLONE; VIRUS RNA;

ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DRUG EFFICACY; FEVER; HOMOSEXUALITY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MYELITIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; POLYMERASE CHAIN REACTION; RASH; RNA ANALYSIS; SORE THROAT; TREATMENT OUTCOME; URINE RETENTION; WESTERN BLOTTING;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; MALE; METHYLPREDNISOLONE; MYELITIS, TRANSVERSE; TREATMENT OUTCOME;

EID: 79961181027     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.5186     Document Type: Article

References (16)

1. Mielke J. Neurological complications of human immunodeficiency virus infection in Zimbabwe-2005. J Neurovirol 11 (Suppl 3): 23-25, 2005.
2. Bell SK, Little SJ, Rosenberg ES. Clinical management of acute HIV infection: best practice remains unknown. J Infect Dis 202 (Suppl 3): S278-S288, 2010.
3. Denning DW, Anderson J, Rudge P, Smith H. Acute myelopathy associated with primary infection with human immunodeficiency virus. Br Medl J (Clinical Res Ed) 294: 143-144, 1987.
4. Frohman EM, Wingerchuk DM. Clinical practice. Transverse myelitis. N Engl J Med 363: 564-572, 2010.
5. Group TMCW. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59: 499-505, 2002.
6. Fux CA, Pfister S, Nohl F, Zimmerli S. Cytomegalovirus-associated acute transverse myelitis in immunocompetent adults. Clin Microbiol Infect 9: 1187-1190, 2003.
7. Karacostas D, Christodoulou C, Drevelengas A, et al. Cytomegalovirus-associated transverse myelitis in a non-immunocompromised patient. Spinal Cord 40: 145-149, 2002.
8. de Seze J, Lanctin C, Lebrun C, et al. Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology 65: 1950-1953, 2005.
9. Kaplin AI, Krishnan C, Deshpande DM, Pardo CA, Kerr DA. Diagnosis and management of acute myelopathies. Neurologist 11: 2-18, 2005.
10. Greenberg BM, Thomas KP, Krishnan C, Kaplin AI, Calabresi PA, Kerr DA. Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide. Neurology 68: 1614-1617, 2007.
11. Kerr DA, Ayetey H. Immunopathogenesis of acute transverse myelitis. Current Opinion in Neurology 15: 339-347, 2002.
12. Kassutto S, Rosenberg ES. Primary HIV type 1 infection. Clin Infect Dis 38: 1447-1453, 2004.
13. Hicks CB, Gay C, Ferrari G. Acute HIV infection: the impact of anti-retroviral treatment on cellular immune responses. Clin Exp Immunol 149: 211-216, 2007.
14. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med 339: 33-39, 1998.
15. Wong TY, So MK. Primary human immunodeficiency virus infection: heightened awareness needed. Hong Kong Med J 7: 205-208, 2001.
16. Furusyo N, Ariyama I, Chong Y, et al. A patient with primary human immunodeficiency virus infection for whom highly active an-tiretroviral therapy was successful. J Infect Chemother 8: 361-364, 2002.